BFM
LAB icon

Boothbay Fund Management’s Standard BioTools LAB Stock Holding History

Boothbay Fund Management’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$66.7K Buy
+72,608
New +$87.9K ﹤0.01% 1904
2025
Q4 		– Sell
-36,714
Closed -$47.7K – 2173
2025
Q3 		$47.7K Buy
+36,714
New +$48.1K ﹤0.01% 1789
2024
Q3 		– Sell
-73,190
Closed -$130K – 1783
2024
Q2 		$130K Sell
73,190
-258,472
-78% -$632K ﹤0.01% 1331
2024
Q1 		$899K Sell
331,662
-476,196
-59% -$1.15M 0.02% 790
2023
Q4 		$1.79M Sell
807,858
-398,156
-33% -$850K 0.05% 534
2023
Q3 		$3.5M Sell
1,206,014
-1,096,264
-48% -$2.87M 0.08% 321
2023
Q2 		$4.44M Hold
2,302,278
– – 0.1% 253
2023
Q1 		$4.49M Hold
2,302,278
– – 0.09% 289
2022
Q4 		$2.69M Hold
2,302,278
– – 0.06% 473
2022
Q3 		$2.53M Sell
2,302,278
-18,844
-0.8% -$28.5K 0.06% 452
2022
Q2 		$3.71M Buy
2,321,122
+18,844
+0.8% +$46.6K 0.1% 294
2022
Q1 		$8.27M Hold
2,302,278
– – 0.19% 100
2021
Q4 		$9.03M Hold
2,302,278
– – 0.21% 95
2021
Q3 		$15.2M Hold
2,302,278
– – 0.42% 32
2021
Q2 		$14.2M Buy
2,302,278
+1,837,258
+395% +$9.82M 0.46% 25
2021
Q1 		$2.1M Buy
+465,020
New +$2.55M 0.08% 304

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Boothbay Fund Management's LAB Position: Q1 2026 in Review

Boothbay Fund Management opened a new position in Standard BioTools (LAB) in Q1 2026: 72,608 shares worth $66.7K. The stake represents ﹤0.01% of the portfolio and ranks #1904 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in LAB as recently as Q3 2025.

Boothbay Fund Management first reported a position in LAB in Q1 2021 and has held it in 16 quarters since. The position peaked at $15.2M in Q3 2021. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

  • Boothbay Fund Management held 72,608 shares of Standard BioTools worth $66.7K as of Q1 2026.
  • Standard BioTools was a new Boothbay Fund Management position in Q1 2026.
  • Standard BioTools made up ﹤0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1904 holding.
  • Boothbay Fund Management first reported a position in Standard BioTools in Q1 2021 and has held it in 16 quarters since.
  • Boothbay Fund Management's Standard BioTools position peaked at $15.2M in Q3 2021.
  • 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.